Tobacco smoking is associated with alterations in several factors considered to be important in the atherosclerotic process. Thirty chronic smokers were studied 2 weeks before and 2 weeks after complete tobacco withdrawal. Significant reductions in fibrinogen, haematocrit, plasma viscosity and whole blood viscosity as well as a significant increase in HDL-cholesterol were observed. As these factors are important in both atherogenesis and thrombogenesis, these observations may give insight into tobacco-induced atherosclerotic disease and may be responsible for the more rapid reduction in the incidence of cardiovascular disease that is believed to occur after stopped smoking.
KannelB.Hypertension and other risk factors in coronary heart disease.Am Heart J1987; 114: 918–25
2.
GottoA.M.Interaction of the major risk factors for coronary heart disease.Am J Med1986; 80(suppl 2A): 48–55
3.
WilhelmsenC., ElmfeldtD., VedinJ.A., TibblinG., WilhelmsenL.Smoking and myocardial infarction.Lancet1975; i: 415–20
4.
AbergA., BergstrandR., JohanssonS.. Cessation of smoking after myocardial infarction effects on mortality after 10 years.Br Heart J1983; 49: 416–22
5.
MulcahyR.Influence of cigarette smoking on morbidity and mortality after myocardial infarction.Br Heart J1983; 49: 410–15
6.
SparrowD., DawberT.R., ColtonT.The influence of cigarette smoking on prognosis after first myocardial infarction.J Chronic Dis1978; 31: 425–32
7.
PohojelaS., SiltanaP., RemoM.. Effect of quitting smoking on the long-term survival after myocardial infarction (abstract).Trans Euro Soc Cardiol1979; 1: 2
8.
SalonenJ.T.Stopping smoking and long-term mortality after acute myocardial infarction.Br Heart J1980; 43: 463–9
9.
RossR.The pathogenesis of atherosclerosis - an update.N Engl J Med1986; 314: 8: 488–500
10.
SmithE.B.Fibrinogen, Fibrin and Fibrin degradation products in relation to atherosclerosis.Clin Haematol1986; 15: 355–70
11.
LoweG.D.O., ForbesC.D.Blood rheology and thrombosis.Clin Haematol1981; 10: 343–67
12.
WoolfN.Thrombosis and atherosclerosis.Br Med Bull1978; 34: 137–42
13.
ErnstE., MatraiA., SchmolzlCh, MagyerosyI.Dose-effect relationship between smoking and blood rheology.Br J Haematol1987; 65: 485–7
14.
MeadeT.W., ImesonJ., StirlingY.Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.Lancet1987; i: 986–8
15.
MustardJ.F., MurphyE.A.Effect of smoking on blood coagulation and platelet survival in man.Br Med J1963; i: 846–9
16.
BillimoriaJ.D., PoznerH., MetselaarB., BestF.W., JamesD.C.O.Effect of cigarette smoking on lipids, lipoproteins, blood coagulation, fibrinolysis and cellular components of human blood.Atherosclerosis1975; 21: 61–76
17.
SiessW., LorenzR., RothP., WeberP.C.Plasma catecholamine, platelet aggregation and associated thromboxane formation after physical exercise, smoking and norepinephrine infusion.Circulation1982; 66: 44–8
RichmondW., SeviourP.W., TealT.K., ElkelesR.S.Impaired intravascular lipolysis with changes in concentration of high density lipoprotein subclasses in young smokers.Br Med J1987; 295: 246–7
20.
ToppingD.L., DwyerT., WellerR.A.Peripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants.Lancet1977; ii: 1327–8
21.
BeckettA.H., TriggE.J.Determination of nicotine and its metabolite, cotinine, in urine by gas chromatography.Nature1966; 211: 1415–17
22.
RamplingM.W., GaffneyP.J.The sulphite precipitation method for fibrinogen measurement; its use on small samples in the presence of Fibrinogen degradation products.Clin Chim Acta1976; 67: 43–52
23.
KingsleyG.R.The Direct Biuret Method for the determination of serum proteins as applied to photoelectric and visual colorimetry.J Lab Clin Med1942; 27: 840–5
24.
De SchepperP.J., van HeckenA., DaerensP., van RossenJ.M.Kinetics of cotinine after oral and intravenous administration to man.Eur J Clin Pharmacol1987; 31: 583–8
25.
ZimmormanM., McGeachieJ.The effect of nicotine on aortic endothelium: a quantitative ultrastructural study.Atherosclerosis1987; 63: 33–41
26.
StoneM.C., ThorpJ.M.Plasma fibrinogen - a major coronary risk factor.J R Coll Gen Pract1985; 35: 565–9
27.
WilhelmsenL., SvardsuddK., Korsan-BergtsenK., LarssenB., WelinL., TibblinG.Fibrinogen as a risk factor for stroke and myocardial infarction.N Engl J Med1984; 311: 501–5
28.
MeadeT.W.. Haemostatic function and ischaemic heart disease: principal results of The Northwick Park Heart Study.Lancet1986; ii: 533–7
29.
KannelW.B., WolfP.A., CastelliW.P., d'AgostinoR.B.Fibrinogen and risk of cardiovascular disease.JAMA1987; 258: 1183–6
30.
RitchieD.G., FullerG.P.Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein.Ann NY Acad Sci1983; 408: 490–502
31.
BennettN.B., OgstonC.M., McAndrewG.M., OgstonD.Studies in the fibrinolytic enzyme system in obesity.J Clin Path1966; 19: 241–3
WoodP.D., StefanickM.L., DreanD.M.. Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise.N Engl J Med1988; 319: 1173–9
34.
HaskellW.L., CamargoC., WilliamsP.T., VranizanK.M., KraussR.M., LindgreenF.T., WoodP.D.The effect of cessation and resumption of moderate alcohol intake on serum high density lipoprotein subfractions.N Engl J Med 84; 310: 805–10
35.
MarkhamM.Falling haematocrit values on cessation of smoking.JAMA1981; 245: 1314
36.
StubbeI., EskilssonJ., Nilsson-EhleP.High density lipoprotein concentration increase after stopping smoking.Br Med J1982; 284: 1511–13
